FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996910928> ?p ?o ?g. }

• W1996910928 endingPage "12" @default.
• W1996910928 startingPage "7" @default.
• W1996910928 abstract "Abstract Background. Targeted ERBB2/HER2 inhibitors are approved by the U.S. Food and Drug Administration for the treatment of breast, gastric, and esophageal cancers that overexpress or amplify HER2/ERBB2, as measured by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH), respectively. Activating mutations in ERBB2 have also been reported and are predicted to confer sensitivity to these targeted agents. Testing for these mutations is not performed routinely, and FISH and IHC are not applied outside of these approved indications. Materials and Methods. We explored the spectrum of activating ERBB2 alterations across a collection of ∼7,300 solid tumor specimens that underwent comprehensive genomic profiling using next-generation sequencing. Results were analyzed for base substitutions, insertions and deletions, select rearrangements, and copy number changes. Results. Known oncogenic ERBB2 alterations were identified in tumors derived from 27 tissues, and ERBB2 amplification in breast, gastric, and gastroesophageal cancers accounted for only 30% of these alterations. Activating mutations in ERBB2 were identified in 131 samples (32.5%); amplification was observed in 246 samples (61%). Two samples (0.5%) harbored an ERBB2 rearrangement. Ten samples (2.5%) harbored multiple ERBB2 mutations, yet mutations and amplifications were mutually exclusive in 91% of mutated cases. Conclusion. Standard slide-based tests for overexpression or amplification of ERBB2 would fail to detect the majority of activating mutations that occur overwhelmingly in the absence of copy number changes. Compared with current clinical standards, comprehensive genomic profiling of a more diverse set of tumor types may identify ∼3.5 times the number of patients who may benefit from ERBB2-targeted therapy." @default.
• W1996910928 created "2016-06-24" @default.
• W1996910928 creator A5003901411 @default.
• W1996910928 creator A5011609796 @default.
• W1996910928 creator A5029183165 @default.
• W1996910928 creator A5035120516 @default.
• W1996910928 creator A5046209356 @default.
• W1996910928 creator A5048608729 @default.
• W1996910928 creator A5061636658 @default.
• W1996910928 creator A5063661642 @default.
• W1996910928 creator A5073531557 @default.
• W1996910928 creator A5079433880 @default.
• W1996910928 creator A5088559019 @default.
• W1996910928 creator A5088809839 @default.
• W1996910928 date "2014-12-05" @default.
• W1996910928 modified "2023-10-15" @default.
• W1996910928 title "Oncogenic Alterations in <i>ERBB2/HER2</i> Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin" @default.
• W1996910928 cites W1838685504 @default.
• W1996910928 cites W1875770431 @default.
• W1996910928 cites W1983917177 @default.
• W1996910928 cites W1989773675 @default.
• W1996910928 cites W1990774346 @default.
• W1996910928 cites W1992678427 @default.
• W1996910928 cites W1994655768 @default.
• W1996910928 cites W2018336040 @default.
• W1996910928 cites W2021053102 @default.
• W1996910928 cites W2038081635 @default.
• W1996910928 cites W2039369850 @default.
• W1996910928 cites W2040935952 @default.
• W1996910928 cites W2042378775 @default.
• W1996910928 cites W2048664966 @default.
• W1996910928 cites W2049449785 @default.
• W1996910928 cites W2075657881 @default.
• W1996910928 cites W2079078036 @default.
• W1996910928 cites W2082592896 @default.
• W1996910928 cites W2084993196 @default.
• W1996910928 cites W2085470185 @default.
• W1996910928 cites W2095618958 @default.
• W1996910928 cites W2095659509 @default.
• W1996910928 cites W2096198395 @default.
• W1996910928 cites W2096628771 @default.
• W1996910928 cites W2100439220 @default.
• W1996910928 cites W2103894337 @default.
• W1996910928 cites W2107562400 @default.
• W1996910928 cites W2110444464 @default.
• W1996910928 cites W2112854176 @default.
• W1996910928 cites W2114843025 @default.
• W1996910928 cites W2118912064 @default.
• W1996910928 cites W2133867160 @default.
• W1996910928 cites W2133952555 @default.
• W1996910928 cites W2135051816 @default.
• W1996910928 cites W2137776025 @default.
• W1996910928 cites W2146384083 @default.
• W1996910928 cites W2149441684 @default.
• W1996910928 cites W2149908785 @default.
• W1996910928 cites W2150089969 @default.
• W1996910928 cites W2155794195 @default.
• W1996910928 cites W2160981405 @default.
• W1996910928 cites W2163250226 @default.
• W1996910928 cites W2164418361 @default.
• W1996910928 cites W2166084034 @default.
• W1996910928 cites W2318605753 @default.
• W1996910928 cites W4230898573 @default.
• W1996910928 cites W4247435334 @default.
• W1996910928 doi "https://doi.org/10.1634/theoncologist.2014-0234" @default.
• W1996910928 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4294606" @default.
• W1996910928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25480824" @default.
• W1996910928 hasPublicationYear "2014" @default.
• W1996910928 type Work @default.
• W1996910928 sameAs 1996910928 @default.
• W1996910928 citedByCount "66" @default.
• W1996910928 countsByYear W19969109282015 @default.
• W1996910928 countsByYear W19969109282016 @default.
• W1996910928 countsByYear W19969109282017 @default.
• W1996910928 countsByYear W19969109282018 @default.
• W1996910928 countsByYear W19969109282019 @default.
• W1996910928 countsByYear W19969109282020 @default.
• W1996910928 countsByYear W19969109282021 @default.
• W1996910928 countsByYear W19969109282022 @default.
• W1996910928 countsByYear W19969109282023 @default.
• W1996910928 crossrefType "journal-article" @default.
• W1996910928 hasAuthorship W1996910928A5003901411 @default.
• W1996910928 hasAuthorship W1996910928A5011609796 @default.
• W1996910928 hasAuthorship W1996910928A5029183165 @default.
• W1996910928 hasAuthorship W1996910928A5035120516 @default.
• W1996910928 hasAuthorship W1996910928A5046209356 @default.
• W1996910928 hasAuthorship W1996910928A5048608729 @default.
• W1996910928 hasAuthorship W1996910928A5061636658 @default.
• W1996910928 hasAuthorship W1996910928A5063661642 @default.
• W1996910928 hasAuthorship W1996910928A5073531557 @default.
• W1996910928 hasAuthorship W1996910928A5079433880 @default.
• W1996910928 hasAuthorship W1996910928A5088559019 @default.
• W1996910928 hasAuthorship W1996910928A5088809839 @default.
• W1996910928 hasBestOaLocation W19969109281 @default.
• W1996910928 hasConcept C104317684 @default.
• W1996910928 hasConcept C120821319 @default.
• W1996910928 hasConcept C121608353 @default.
• W1996910928 hasConcept C126322002 @default.

• next